First large test shows vaccine prevents cervical cancer

TRENTON, N.J. (AP) - The first major study of an experimental vaccine to prevent cervical cancer found it was 100 per cent effective, in the short term, at blocking the disease and lesions likely to turn cancerous, drug maker Merck & Co said....More